Literature DB >> 1655283

A novel T. cruzi heparin-binding protein promotes fibroblast adhesion and penetration of engineered bacteria and trypanosomes into mammalian cells.

E Ortega-Barria1, M E Pereira.   

Abstract

T. cruzi invades mammalian cells in various organs after migrating through the ECM. These activities appear to be mediated by a unique 60 kd protein exposed on the T. cruzi surface, which promotes selective adhesion of trypomastigotes to three ECM components: heparin, heparan sulfate, and collagen. The affinity-purified protein binds to host fibroblasts in a saturable and glycosaminoglycan- and collagen-inhibitable manner. When adsorbed to plastic, it promotes adhesion and spreading of fibroblasts, as does the recombinant protein expressed in E. coli. The endogenous protein, and reactive ECM proteins, are very effective in preventing T. cruzi invasion of culture cells. The recombinant protein localizes on the E. coli surface and induces the bacteria that express it to adhere to and penetrate nonphagocytic Vero cells in a proteoglycan- and collagen-inhibitable manner. Therefore, the protein, named penetrin, could play a critical role in T. cruzi binding to the ECM and to cells, and in host cell invasion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655283     DOI: 10.1016/0092-8674(91)90192-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  67 in total

1.  Sulfated polysaccharide-directed recruitment of mammalian host proteins: a novel strategy in microbial pathogenesis.

Authors:  T D Duensing; J S Wing; J P van Putten
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Eukaryotic cell uptake of heparin-coated microspheres: a model of host cell invasion by Chlamydia trachomatis.

Authors:  R S Stephens; F S Fawaz; K A Kennedy; K Koshiyama; B Nichols; C van Ooij; J N Engel
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Characterization of the cell adhesion site of Trypanosoma cruzi metacyclic stage surface glycoprotein gp82.

Authors:  P M Manque; D Eichinger; M A Juliano; L Juliano; J E Araya; N Yoshida
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV.

Authors:  J M Santana; P Grellier; J Schrével; A R Teixeira
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

Review 5.  Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications.

Authors:  Allison H Bartlett; Pyong Woo Park
Journal:  Expert Rev Mol Med       Date:  2010-02-01       Impact factor: 5.600

Review 6.  Mechanisms of Trypanosoma cruzi persistence in Chagas disease.

Authors:  Fnu Nagajyothi; Fabiana S Machado; Barbara A Burleigh; Linda A Jelicks; Philipp E Scherer; Shankar Mukherjee; Michael P Lisanti; Louis M Weiss; Nisha J Garg; Herbert B Tanowitz
Journal:  Cell Microbiol       Date:  2012-02-24       Impact factor: 3.715

7.  Cell-specific activation of nuclear factor-kappaB by the parasite Trypanosoma cruzi promotes resistance to intracellular infection.

Authors:  B S Hall; W Tam; R Sen; M E Pereira
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

8.  The Yersinia pseudotuberculosis adhesin YadA mediates intimate bacterial attachment to and entry into HEp-2 cells.

Authors:  J B Bliska; M C Copass; S Falkow
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  Effects of dextran sulfates on the acute infection and growth stages of Toxoplasma gondii.

Authors:  Akiko Ishiwa; Kyousuke Kobayashi; Hitoshi Takemae; Tatsuki Sugi; Haiyan Gong; Frances C Recuenco; Fumi Murakoshi; Atsuko Inomata; Taisuke Horimoto; Kentaro Kato
Journal:  Parasitol Res       Date:  2013-10-06       Impact factor: 2.289

10.  Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro.

Authors:  D H Hamer; H Ward; S Tzipori; M E Pereira; J P Alroy; G T Keusch
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.